scientist at Ralston Purina after he graduated from Cornell University in early 1983.
He then was Vice President at Degussa from 1984 to 1989 prior to joining ADM.
He then was Vice President at Degussa from 1984 to 1989 prior to joining ADM.
In late 1989, Whitacre became the President of the BioProducts Division at ADM.
In the late 1990s Whitacre was sentenced to 9 years in federal prison for embezzling $9.5 million from ADM at the same time he was assisting the federal price-fixing investigation.
In 1992, he was promoted to Corporate Vice President of ADM, as well as being President of the BioProducts Division.
In March 2008, Whitacre was promoted to the company's Chief Operating Officer (COO) and President of operations. ==Legal issues== === ADM price-fixing === In 1992, during an ADM-initiated investigation of corporate espionage and sabotage, Whitacre informed an FBI agent that he and other ADM executives were involved in an illegal multinational lysine price-fixing scheme.
Mark Edward Whitacre is an American business executive who came to public attention in 1995 when, as president of the Decatur, Illinois-based BioProducts Division at Archer Daniels Midland (ADM), he became the highest-level corporate executive in U.S.
On August 9, 1995, Whitacre was terminated for conducting a $9.5 million fraud after ADM learned that he was an FBI informant for three years.
history, against ADM. After leaving ADM in August 1995, Whitacre was hired as the CEO of Future Health Technologies (FHT), which soon was renamed Biomar International.
He worked at Biomar until his incarceration began during early 1998. In December 2006, after his release from federal prison, Whitacre was hired by Cypress Systems Inc., a California biotechnology company, as the President of Technology and Business Development.
Whitacre was later convicted of embezzling $9 million; some of this criminal activity occurred during the time he was cooperating with the FBI. ===Sentencing and release=== Whitacre pled guilty to tax evasion and fraud and was sent to prison on March 4, 1998.
In December 2006, he was released on good behavior after serving eight and a half years. ===Differing perspectives=== ==== Kurt Eichenwald ==== In his 2000 book, The Informant, Kurt Eichenwald, a former The New York Times reporter, portrays Whitacre as a complex figure: while working for the FBI as one of the best and most effective undercover cooperating witnesses the U.S.
He was released in December 2006.
He worked at Biomar until his incarceration began during early 1998. In December 2006, after his release from federal prison, Whitacre was hired by Cypress Systems Inc., a California biotechnology company, as the President of Technology and Business Development.
In December 2006, he was released on good behavior after serving eight and a half years. ===Differing perspectives=== ==== Kurt Eichenwald ==== In his 2000 book, The Informant, Kurt Eichenwald, a former The New York Times reporter, portrays Whitacre as a complex figure: while working for the FBI as one of the best and most effective undercover cooperating witnesses the U.S.
In March 2008, Whitacre was promoted to the company's Chief Operating Officer (COO) and President of operations. ==Legal issues== === ADM price-fixing === In 1992, during an ADM-initiated investigation of corporate espionage and sabotage, Whitacre informed an FBI agent that he and other ADM executives were involved in an illegal multinational lysine price-fixing scheme.
All text is taken from Wikipedia. Text is available under the Creative Commons Attribution-ShareAlike License .
Page generated on 2021-08-05